This program provides an efficient way to explore state-of-the-art AML and MDS treatment options and decision-making algorithms. In this session, you will learn about the role of multi-center clinical trials in expanding transplantation access and identifying optimal treatment approaches for patients with AML and MDS.
Dennis Confer, M.D.
Chief Medical Officer
National Marrow Donor Program
- Summarize trends in rates and types of blood and marrow transplantation as well as donor availability over time
- Describe the goals, organization and impact of the Blood and Marrow Transplant Clinical Trials Network
- Identify currently enrolling and proposed clinical trials that are or may soon be available to patients through the Blood and Marrow Transplant Clinical Trials Network
- Discuss the goals and new approaches of the National Marrow Donor Program
The goal of this activity is to provide physicians and other health care professionals with information that impacts the treatment algorithms for AML and MDS, such as the role of risk stratification, the outcomes of chemotherapy and transplantation and the state of current clinical trials.
This activity is intended for hematologists/oncologists, transplant physicians and other health care professionals.
If you have any questions regarding this program, call Renee Ryan at (800) 526-7809 ext. 8430, or e-mail firstname.lastname@example.org.